Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Log In

Treatment Paradigms In AMD Management Webinar Part 3

By: Ivan J. Suner, MD, MBA

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

Expiration Date: Tuesday, April 30, 2019
Release Date: April 24, 2018

Learning Objectives

Learning objectives

Upon completion of this activity, participants will be better able to:

  • Understand the most recent monotherapy and combination therapy clinical study evidence using available therapies for AMD, DME, and RVO
  • Discuss the outcomes of pivotal studies in AMD, DME, and RVO and how study results may differ from “real-world” dosing methods
  • Develop individualized treatment plans for patients with retina disorders that use a combination of imaging, treat and extend, or treat and observe
  • Discuss the ocular and systemic effects of anti-VEGF therapies and how to educate patients on appropriate expectations.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

Ivan J. Suner, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alimera Sciences; Allergan plc; Santen; and Genentech. Grant/Research Support: Allergan plc; and Genentech. Speaker’s Bureau: Genentech; and Regeneron Pharmaceuticals.

Editorial Support Disclosures

Erin K. Fletcher, MIT, director of compliance and education, Evolve; and Michelle Dalton, writer, have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has no financial relationships with commercial interests.


Off-Label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, or Regeneron Pharmaceuticals Inc.

Video Resources